OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story
Charles Gore, Sébastien Morin, John‐Arne Røttingen, et al.
BMJ Global Health (2023) Vol. 8, Iss. 9, pp. e012964-e012964
Open Access | Times Cited: 14

Showing 14 citing articles:

Advancing global antibiotic research, development and access
Laura J. V. Piddock, Yewande Alimi, James L. Anderson, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2432-2443
Closed Access | Times Cited: 11

Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics
Rebecca R. Martin, Allan Maleche, Jill Gay, et al.
BMJ Global Health (2024) Vol. 9, Iss. 1, pp. e013680-e013680
Open Access | Times Cited: 8

Lenacapavir to prevent HIV infection: current prices versus estimated costs of production
Andrew Hill, Jacob Levi, Cassandra Fairhead, et al.
Journal of Antimicrobial Chemotherapy (2024)
Closed Access | Times Cited: 4

Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response
Tiwadayo Braimoh, Esteban Burrone, Charles Gore, et al.
Globalization and Health (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2

Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries
Shelly Malhotra, A.G.W. Cameron, Dzintars Gotham, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 7, pp. e0003418-e0003418
Open Access | Times Cited: 1

‘Our project, your problem?’ A case study of the WHO’s mRNA technology transfer programme in South Africa
Matthew Herder, Ximena Benavides
PLOS Global Public Health (2024) Vol. 4, Iss. 9, pp. e0003173-e0003173
Open Access | Times Cited: 1

Why is roll-out of long-acting PrEP agents so slow?
Rupa Patel, Kenneth H. Mayer
Current Opinion in HIV and AIDS (2024) Vol. 20, Iss. 1, pp. 48-53
Closed Access | Times Cited: 1

Intellectual Property and Health Technological Innovations at the time of the Pandemic
Nadia Naim, Hui Yun Chan
The Law and Development Review (2024)
Closed Access

The Regulatory Landscape of Biobanks In Europe: From Accreditation to Intellectual Property
Antonella Corradi, Giuseppina Bonizzi, Elham Sajjadi, et al.
Current Genomics (2024) Vol. 26, Iss. 1, pp. 15-23
Closed Access

Balancing Innovation and Access
Karun Sanjaya, P. R. L. Rajavenkatesan
Advances in electronic government, digital divide, and regional development book series (2024), pp. 161-173
Closed Access

Tinkering in Markets for Collective Goods: Experiments, Exceptionalities and the Case of HIV Medications
Nicole Gross, Susi Geiger
Cambridge University Press eBooks (2024), pp. 23-37
Closed Access

Market Designs and Market Misfires
Susi Geiger
Cambridge University Press eBooks (2024), pp. 19-96
Closed Access

Page 1

Scroll to top